General Information of the Compound
| Compound ID |
CP0415736
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(4R)-4-(3,4-dimethoxyphenyl)-4-[3-oxo-7-[4-[(1R)-1-phenylethyl]piperazin-1-yl]-1H-isoindol-2-yl]butyl]-5-methyl-1,2-oxazole-4-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C37H43N5O5
|
||||||||||||||||||
| Molecular Weight |
637.781
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(cc1OC)[C@@H](CCCNC(=O)c1cnoc1C)N1Cc2c(cccc2N2CCN(CC2)[C@H](C)c2ccccc2)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C37H43N5O5/c1-25(27-10-6-5-7-11-27)40-18-20-41(21-19-40)33-13-8-12-29-31(33)24-42(37(29)44)32(28-15-16-34(45-3)35(22-28)46-4)14-9-17-38-36(43)30-23-39-47-26(30)2/h5-8,10-13,15-16,22-23,25,32H,9,14,17-21,24H2,1-4H3,(H,38,43)/t25-,32-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
WYGHIDQLPZLSFF-NLGDKJDOSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03174, Urotensin-2 receptor
Protein ID: PT02463, Urotensin-2 receptor